Tri-O-benzoyl-2-C-methyl-D-ribofuranose, 16434-48-3, CAS:16434-48-3

2-C-Methyl-1,3,5-tri-O-benzoyl-alpha-D-ribofuranoside, also known as MTR, is a nucleoside analog that has been studied for its potential biological and pharmaceutical applications. In this paper, we will explore the definition and background of MTR, physical and chemical properties, synthesis and characterization, analytical methods, biological properties, toxicity and safety in scientific experiments, applications in scientific experiments, current state of research, potential implications in various fields of research and industry, limitations, and future directions. Definition and Background: 2-C-Methyl-1,3,5-tri-O-benzoyl-alpha-D-ribofuranoside is a nucleoside analog that is structurally similar to adenosine. It was first synthesized and characterized in 1994 as a novel compound with potential anti-viral and anti-cancer activity. Since then, it has been extensively studied for its biological and pharmaceutical properties. Synthesis and Characterization: MTR can be synthesized using a multi-step chemical process that involves protecting the hydroxyl groups of ribose with benzoyl groups, and subsequently methylating the 2? carbon. The final product is purified using column chromatography and characterized using nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry. Analytical Methods: MTR can be quantified using high-performance liquid chromatography (HPLC) with UV detection. The purity and identity of MTR can be confirmed using NMR spectroscopy, mass spectrometry, and infrared spectroscopy. Biological Properties: MTR has been studied for its potential anti-viral, anti-cancer, and anti-inflammatory properties. It was found to inhibit the replication of herpes simplex virus type 1 (HSV-1) and adenovirus in cell culture, and to induce apoptosis in cancer cells. MTR was also shown to reduce the production of cytokines and chemokines in macrophages, indicating its potential as an anti-inflammatory agent. Toxicity and Safety in Scientific Experiments: MTR has been shown to be relatively safe in vitro and in vivo experiments, with no significant toxicity reported at concentrations up to 100 ?M. However, further studies are needed to determine its potential toxicity and safety in higher concentrations or long-term exposure. Applications in Scientific Experiments: MTR has been used in various scientific experiments as a chemical probe to investigate the biological activity of adenosine analogs. It has also been used as a substrate for enzymes involved in nucleic acid metabolism, as well as a precursor for the synthesis of other nucleoside analogs. Current State of Research: Research on MTR is ongoing, with several studies focused on its potential as an anti-viral, anti-cancer, and anti-inflammatory agent. In addition, its use as a chemical probe in enzymatic assays and as a precursor for the synthesis of other nucleoside analogs is also being explored. Potential Implications in Various Fields of Research and Industry: The potential applications of MTR are diverse, and include its use as a therapeutic agent for viral infections and cancer, as well as its use as a chemical probe in biochemical and pharmacological studies. In addition, MTR may have applications in the development of new drugs and pharmaceuticals, as well as in the field of nucleic acid biosensing. Limitations: Despite its potential applications, there are also limitations to the use of MTR. One major limitation is its relatively low solubility in water, which may restrict its use in some experiments. In addition, further studies are needed to determine its potential toxicity and safety in higher concentrations or long-term exposure. Future Directions: There are several future directions for research on MTR. One potential area of investigation is its use as a therapeutic agent for viral infections and cancer, and further studies are needed to determine its efficacy and safety in this regard. In addition, MTR may have applications in the field of nucleic acid biosensing, and further studies are needed to optimize its use in this regard. Other potential future directions for research on MTR include its use as a chemical probe in biochemical and pharmacological studies, and its use as a precursor for the synthesis of other nucleoside analogs. CAS Number 16434-48-3 Product Name 2-C-Methyl-1,3,5-tri-O-benzoyl-alpha-D-ribofuranoside IUPAC Name [(2R,3R,4R,5R)-3,5-dibenzoyloxy-4-hydroxy-4-methyloxolan-2-yl]methyl benzoate Molecular Formula C27H24O8 Molecular Weight 476.475 InChI InChI=1S/C27H24O8/c1-27(31)22(34-24(29)19-13-7-3-8-14-19)21(17-32-23(28)18-11-5-2-6-12-18)33-26(27)35-25(30)20-15-9-4-10-16-20/h2-16,21-22,26,31H,17H2,1H3/t21-,22-,26-,27-/m1/s1 SMILES CC1(C(C(OC1OC(=O)C2=CC=CC=C2)COC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4)O